Terrace Biotech 生產(chǎn)特異性針對(duì)人肺泡1型和2型的胞的特異性抗體

Terrace Biotech 的專業(yè)知識(shí)源于 UCSF 醫(yī)學(xué)中心的肺研究小組，該小組幫助表征了肺表面活性物質(zhì)，然后開(kāi)發(fā)了一種合成形式，用于治療患有呼吸窘迫綜合征的早產(chǎn)兒。Terrace Biotech 擁有超過(guò) 25 年的肺細(xì)胞生物學(xué)研究經(jīng)驗(yàn)，將其專業(yè)知識(shí)應(yīng)用于醫(yī)學(xué)研究的進(jìn)一步創(chuàng)新和改善人類健康。

Group at UCSF Medical Center that helped characterize pulmonary surfactant and then developed a synthetic form of it that is used to treat premature infants with respiratory distress syndrome. With over twenty-five years of 'hands on' research experience in lung cell biology, Terrace Biotech applies its expertise to further innovation in medical research and improve human health.

Terrace Biotech 生產(chǎn)特異性針對(duì)人肺泡1型和2型的胞的特異性抗體。抗體被廣泛應(yīng)用于：免疫組化、Western Blot,流式細(xì)胞分離，細(xì)胞分選等。靶點(diǎn)科技現(xiàn)貨庫(kù)存，歡迎訂購(gòu)。背景知識(shí)介紹見(jiàn)靶點(diǎn)商城。

產(chǎn)品信息：